2342.T Stock - Trans Genic Inc.
Unlock GoAI Insights for 2342.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $13.01B | $13.08B | $11.43B | $12.58B | $11.05B |
| Gross Profit | $2.17B | $2.25B | $1.99B | $3.84B | $2.78B |
| Gross Margin | 16.7% | 17.2% | 17.5% | 30.5% | 25.1% |
| Operating Income | $-259,507,000 | $89.44M | $-25,150,000 | $1.84B | $893.20M |
| Net Income | $-1,089,641,000 | $4.08M | $-409,668,000 | $1.88B | $546.29M |
| Net Margin | -8.4% | 0.0% | -3.6% | 14.9% | 4.9% |
| EPS | $-65.51 | $0.24 | $-24.32 | $109.52 | $31.45 |
Trans Genic Inc. develops, distributes, and licenses genetically modified animals and antibodies in Japan. It operates through Drug Discovery Support Business and Investment Business segments. The company provides glycan synthesis and analysis services; non-clinical studies for pharmaceuticals, foods, cosmetics, chemical substances, etc., as well as various safety tests for foods, and pharmaceutical agents; and support for bioequivalence test, including clinical trials, pharmacokinetic measurements, and the preparation of clinical trial reports; as well as hospital support services. It also offers drug efficiency and pharmacological test and safety studies; sugar chain analysis and synthesis services; advice and support services, including M&A, business revitalization, business succession services; and contract production services, such as genetically modified mice, antibodies, protein hypers, and expressing cells, as well as sells mouse-related products and mouse models, and research reagents. The company was formerly known as Kumamoto Immunochemical Laboratories Inc. and changed its name to Trans Genic Inc. in April 2000. Trans Genic Inc. was incorporated in 1998 and is headquartered in Fukuoka City, Japan.
Visit WebsiteEarnings History & Surprises
2342.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 12, 2025 | — | $0.16 | — | — |
Q2 2025 | Jun 16, 2025 | — | $-47.92 | — | — |
Q1 2025 | Feb 14, 2025 | — | $-6.57 | — | — |
Q4 2024 | Nov 12, 2024 | — | $-4.98 | — | — |
Q3 2024 | Aug 9, 2024 | — | $-5.99 | — | — |
Q2 2024 | May 10, 2024 | — | $2.55 | — | — |
Q1 2024 | Feb 9, 2024 | — | $-5.15 | — | — |
Q4 2023 | Nov 10, 2023 | — | $-1.76 | — | — |
Q3 2023 | Aug 10, 2023 | — | $4.64 | — | — |
Q2 2023 | May 12, 2023 | — | $-35.10 | — | — |
Q1 2023 | Feb 10, 2023 | — | $7.54 | — | — |
Q4 2022 | Nov 11, 2022 | — | $4.79 | — | — |
Q3 2022 | Aug 12, 2022 | — | $-1.53 | — | — |
Q2 2022 | May 13, 2022 | — | $63.82 | — | — |
Q1 2022 | Feb 14, 2022 | — | $-10.55 | — | — |
Q4 2021 | Nov 12, 2021 | — | $21.52 | — | — |
Q3 2021 | Aug 13, 2021 | — | $35.03 | — | — |
Q2 2021 | May 14, 2021 | — | $5.65 | — | — |
Q1 2021 | Feb 12, 2021 | — | $24.34 | — | — |
Q4 2020 | Nov 12, 2020 | — | $2.09 | — | — |
Latest News
Frequently Asked Questions about 2342.T
What is 2342.T's current stock price?
What is the analyst price target for 2342.T?
What sector is Trans Genic Inc. in?
What is 2342.T's market cap?
Does 2342.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 2342.T for comparison